You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Guanfacine

Showing 1 - 25 of 87
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cannabis Use Disorder Trial in Parkville (Guanfacine Extended Release Oral Tablet, Residential withdrawal, Engagement with

Not yet recruiting
  • Cannabis Use Disorder
  • Guanfacine Extended Release Oral Tablet
  • +3 more
  • Parkville, Victoria, Australia
    Orygen
Jul 16, 2023

Hyperactivity in Children With Down Syndrome, Impulsivity in Children With Down Syndrome Trial (Guanfacine Hydrochloride

Not yet recruiting
  • Hyperactivity in Children With Down Syndrome
  • Impulsivity in Children With Down Syndrome
  • Guanfacine Hydrochloride Immediate Release
  • Placebo
  • (no location specified)
Sep 18, 2023

Critical Illness, Delirium, Cognitive Impairment Trial in Nashville (Guanfacine, Placebo)

Recruiting
  • Critical Illness
  • +2 more
  • Guanfacine
  • Placebo
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jan 9, 2023

Chronic Pain Trial in Boston (Morphine, Guanfacine 1mg, Guanfacine 2mg)

Active, not recruiting
  • Chronic Pain
  • Boston, Massachusetts
    Center for Translational Pain Research
Apr 4, 2022

Cannabis Use Trial in New York (guanfacine-ER, Placebo)

Recruiting
  • Cannabis Use
  • New York, New York
    STARS Clinic at Columbia and NYSPI Department of Psychiatry
Jun 6, 2022

ADHD Trial in London (Lisdexamfetamine dimesylate, Guanfacine Extended Release Oral Tablet, Placebo)

Active, not recruiting
  • ADHD
  • Lisdexamfetamine dimesylate
  • +2 more
  • London, United Kingdom
    Institute of Psychiatry, Psychology & Neuroscience; King's Colle
Aug 16, 2022

Chronic Pain Trial in Boston (Guanfacine, Placebo)

Active, not recruiting
  • Chronic Pain
  • Guanfacine
  • Placebo
  • Boston, Massachusetts
    MGH Center for Translational Pain Research
Apr 4, 2022

Prader-Willi Syndrome, Aggression, Self-Injurious Behavior Trial in Brooklyn (Guanfacine Extended Release, Placebo)

Recruiting
  • Prader-Willi Syndrome
  • +20 more
  • Guanfacine Extended Release
  • Placebo
  • Brooklyn, New York
    Maimonides Medical Center
Dec 20, 2022

Smoking Cessation Trial in New Haven (Varenicline, Guanfacine ER)

Recruiting
  • Smoking Cessation
  • New Haven, Connecticut
    Yale University
Jan 31, 2022

Smoking Cessation Trial in New Haven (Guanfacine, Placebo)

Completed
Has Results
  • Smoking Cessation
  • Guanfacine
  • Placebo
  • New Haven, Connecticut
    Yale Center for Clinical Investigations, Yale University
Nov 30, 2021

Trigeminal Neuralgia Trial in Nashville (Lidocaine, Guanfacine)

Recruiting
  • Trigeminal Neuralgia
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Feb 24, 2022

Alcohol Use Trial in New Haven (Guanfacine ER, Placebo)

Recruiting
  • Alcohol Use
  • Guanfacine ER
  • Placebo
  • New Haven, Connecticut
    Yale University School of Medicine
Mar 11, 2022

MDD Trial in Palo Alto (Guanfacine Pill, Placebo)

Recruiting
  • Major Depressive Disorder
  • Guanfacine Pill
  • Placebo
  • Palo Alto, California
    Stanford Psychiatry
Dec 1, 2022

Delirium Trial in Birmingham (Guanfacine, Placebo)

Recruiting
  • Delirium
  • Guanfacine
  • Placebo
  • Birmingham, Alabama
    University of Alabama at Birmingham Hospital
Nov 17, 2021

Drug Use Study With Intuniv® in European Countries

Active, not recruiting
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • No Intervention
  • Munich, Bavaria, Germany
    Real World Insights EMEA IQVIA Commercial GmbH & Co. OHG
May 12, 2023

ADHD Trial in New York (Guanfacine, Lisdexamfetamine)

Terminated
Has Results
  • Attention Deficit Hyperactivity Disorder
  • New York, New York
    New York State Psychiatric Institute
Jan 18, 2023

Alcohol Drinking Trial in New Haven (Guanfacine 3mg/day, Guanfacine 1.5mg/day, Placebo)

Completed
Has Results
  • Alcohol Drinking
  • Guanfacine 3mg/day
  • +2 more
  • New Haven, Connecticut
    Yale Center for Clinical Investigations, Yale University
Jul 6, 2021

Smoking Trial in New Haven (guanfacine, )

Completed
Has Results
  • Smoking
  • guanfacine
  • placebo
  • New Haven, Connecticut
    Yale Center for Clinical Investigation, Yale University
Aug 1, 2022

Tourette Disorder, Tourette Syndrome Trial in New Haven, Tampa, New York (, extended-release guanfacine (Intuniv))

Completed
Has Results
  • Tourette Disorder
  • Tourette Syndrome
  • placebo
  • extended-release guanfacine (Intuniv)
  • New Haven, Connecticut
  • +2 more
Aug 11, 2021

Healthy Volunteers Trial in Tacoma (immediate release guanfacine HCl, moxifloxacin, Placebo)

Completed
Has Results
  • Healthy Volunteers
  • immediate release guanfacine hydrochloride
  • +2 more
  • Tacoma, Washington
    Charles River Clinical Services Northwest, Inc.
Jun 10, 2021

Stress Disorder Trial in Farmington (Guanfacine Extended Release, Mindfulness Skills Therapy, Placebo)

Withdrawn
  • Stress Disorder
  • Guanfacine Extended Release
  • +2 more
  • Farmington, Connecticut
    UConn Health
Mar 4, 2021

Attention Deficit Disorder With Hyperactivity Trial in Los Angeles (Guanfacine, Methylphenidate (MPH))

Completed
Has Results
  • Attention Deficit Disorder With Hyperactivity
  • Guanfacine
  • Methylphenidate (MPH)
  • Los Angeles, California
    University of California Los Angeles
Jul 9, 2021

Obstructive Sleep Apnea Trial (Guanfacine, Hydrochlorothiazide)

Completed
Has Results
  • Obstructive Sleep Apnea
  • (no location specified)
Nov 10, 2020

Attention Deficit Disorder With Hyperactivity (ADHD) Trial in Stockholm (methylphenidate medication, atomoxetine medication,

Active, not recruiting
  • Attention Deficit Disorder With Hyperactivity (ADHD)
  • methylphenidate medication
  • +3 more
  • Stockholm, Stockholm County, Sweden
    Division for Child and Adolescent Psychiatry in Stockholm
Oct 7, 2021

ADHD Trial in United States (SPD503 (Guanfacine HCl), Placebo)

Completed
Has Results
  • ADHD
  • SPD503 (Guanfacine hydrochloride)
  • Placebo
  • Phoenix, Arizona
  • +33 more
Jun 10, 2021